Amor Salah: 2026 NCS/SCCM Guidelines for Managing Antithrombotic-Associated ICH
Amor Salah, Consulting Associate at MetaQare IntelliHealth, shared a post on LinkedIn about a recent article by Meghan Caylor Vallejo et al, published in Springer Nature, adding:
“2026 NCS/SCCM Guideline Update on Antithrombotic-Associated ICH.
This focused guideline update from the Neurocritical Care Society (NCS) and Society of Critical Care Medicine (SCCM) provides evidence-based recommendations using GRADE methodology for managing acute antithrombotic-associated intracranial hemorrhage (ICH) in adult patients.
Key Recommendations:
1. Factor Xa Inhibitor Reversal:
The panel conditionally recommends 4-factor prothrombin complex concentrate (4F-PCC) over andexanet alfa for both spontaneous intraparenchymal hemorrhage (IPH) and traumatic ICH. Although andexanet alfa improves hemostatic efficacy, meta-analyses show no mortality or functional outcome benefits. Crucially, andexanet alfa increases thrombotic risk. Combining 4F-PCC and andexanet alfa is explicitly advised against.
2. Platelet Transfusion in Antiplatelet Use:
- Spontaneous IPH without Surgery: Suggests against platelet transfusion, as evidence shows no mortality benefit and potential functional harm.
- Spontaneous IPH with Surgery: Suggests platelet transfusion for patients on aspirin undergoing neurosurgical intervention.
- Traumatic ICH: Issues no recommendation due to very low certainty evidence.
3. Desmopressin (DDAVP):
The panel makes no recommendation regarding desmopressin in antiplatelet-associated ICH due to insufficient evidence of clinical efficacy.
4. Small Spontaneous IPH:
Makes no recommendation on reversing anticoagulant effects in small IPH (<5–10 mL) due to lack of direct evidence.
5. Viscoelastic Hemostatic Assays (VHAs):
Conditionally suggests VHA-guided (TEG/ROTEM) management in traumatic ICH when available, supported by potential mortality reduction.”
Title: Treatment of Antithrombotic-Associated Intracranial Hemorrhage in Adults: A Focused Guideline Update from the Neurocritical Care Society and the Society of Critical Care Medicine
Authors: Meghan Caylor Vallejo, Lori S. Kennedy, Bradley Dengler, Colleen Barthol, Emilie P. Belley-Cote, Joseph D. Burns, Veda K. Chau, Charlotte Cordonnier, Adam Cuker, Kimia Honarmand, Sherif Hanafy Mahmoud, M. Elizabeth Wilcox and Monisha A. Kumar

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia